The allure of stem cell therapy for muscular dystrophy.

Duchenne muscular dystrophy (DMD) is a lethal muscle disease for which an effective treatment is urgently needed. The use of stem cells to produce normal muscle cells to replace the missing dystrophin protein has attracted much attention. Claims of success using stem cell treatment in animal models...

Full description

Bibliographic Details
Main Authors: Grounds, MD, Davies, K
Format: Journal article
Language:English
Published: 2007
_version_ 1826296841262596096
author Grounds, MD
Davies, K
author_facet Grounds, MD
Davies, K
author_sort Grounds, MD
collection OXFORD
description Duchenne muscular dystrophy (DMD) is a lethal muscle disease for which an effective treatment is urgently needed. The use of stem cells to produce normal muscle cells to replace the missing dystrophin protein has attracted much attention. Claims of success using stem cell treatment in animal models of human muscle diseases require careful evaluation and are not necessarily easily extrapolated to the clinical situation. Recent studies in the dystrophic dog model have been claimed to show that injected mesangioblasts, stem cells derived from blood vessels, reduce the severity of the disease. However, the authors' interpretation of the results did not consider that benefits might arise from the concomitant use of immunosuppressive drugs alone.
first_indexed 2024-03-07T04:22:33Z
format Journal article
id oxford-uuid:cb83c7ae-de3c-4a81-910a-dbaa4df87172
institution University of Oxford
language English
last_indexed 2024-03-07T04:22:33Z
publishDate 2007
record_format dspace
spelling oxford-uuid:cb83c7ae-de3c-4a81-910a-dbaa4df871722022-03-27T07:15:24ZThe allure of stem cell therapy for muscular dystrophy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cb83c7ae-de3c-4a81-910a-dbaa4df87172EnglishSymplectic Elements at Oxford2007Grounds, MDDavies, KDuchenne muscular dystrophy (DMD) is a lethal muscle disease for which an effective treatment is urgently needed. The use of stem cells to produce normal muscle cells to replace the missing dystrophin protein has attracted much attention. Claims of success using stem cell treatment in animal models of human muscle diseases require careful evaluation and are not necessarily easily extrapolated to the clinical situation. Recent studies in the dystrophic dog model have been claimed to show that injected mesangioblasts, stem cells derived from blood vessels, reduce the severity of the disease. However, the authors' interpretation of the results did not consider that benefits might arise from the concomitant use of immunosuppressive drugs alone.
spellingShingle Grounds, MD
Davies, K
The allure of stem cell therapy for muscular dystrophy.
title The allure of stem cell therapy for muscular dystrophy.
title_full The allure of stem cell therapy for muscular dystrophy.
title_fullStr The allure of stem cell therapy for muscular dystrophy.
title_full_unstemmed The allure of stem cell therapy for muscular dystrophy.
title_short The allure of stem cell therapy for muscular dystrophy.
title_sort allure of stem cell therapy for muscular dystrophy
work_keys_str_mv AT groundsmd theallureofstemcelltherapyformusculardystrophy
AT daviesk theallureofstemcelltherapyformusculardystrophy
AT groundsmd allureofstemcelltherapyformusculardystrophy
AT daviesk allureofstemcelltherapyformusculardystrophy